The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival

References

• Silva RL, Wendel HG MNK. EIF4E and targeting translation for therapy. Cell Cycle 2008; 7:553 - 555
   PubMed Web of Science ®Google Scholar
• Graff JR, Konicek BW, Carter JH, Marcusson EG. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 2008; 68:631 - 634
   PubMed Web of Science ®Google Scholar
• Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 1996; 93:1065 - 1070
   PubMed Web of Science ®Google Scholar
• De Benedetti A, Harris AL. eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 1999; 31:59 - 72
   PubMed Web of Science ®Google Scholar
• Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 2007; 21:3232 - 3237
   PubMed Web of Science ®Google Scholar
• Lazaris-Karatzas A, Sonenberg N. The mRNA 5′ capbinding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. Mol Cell Biol 1992; 12:1234 - 1238
   PubMed Web of Science ®Google Scholar
• Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N. eIF4E—from translation to transformation. Oncogene 2004; 23:3172 - 3179
   PubMed Web of Science ®Google Scholar
• Sorrells DL, Black DR, Meschonat C, Rhoads R, De Benedetti A, Gao M, et al. Detection of eIF4E gene amplification in breast cancer by competitive PCR. Ann Surg Oncol 1998; 5:232 - 237
   PubMed Web of Science ®Google Scholar
• Sorrells DL, Ghali GE, Meschonat C, DeFatta RJ, Black D, Liu L, et al. Competitive PCR to detect eIF4E gene amplification in head and neck cancer. Head Neck 1999; 21:60 - 65
   PubMed Web of Science ®Google Scholar
• Berkel HJ, Turbat-Herrera EA, Shi R, de Benedetti A. Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon. Cancer Epidemiol Biomarkers Prev 2001; 10:663 - 666
   PubMed Web of Science ®Google Scholar
• Matthews-Greer J, Caldito G, de Benedetti A, Herrera GA, Dominguez-Malagon H, Chanona-Vilchis J, et al. eIF4E as a marker for cervical neoplasia. Appl Immunohistochem Mol Morphol 2005; 13:367 - 370
   PubMedGoogle Scholar
• Wang R, Geng J, Wang JH, Chu XY, Geng HC, Chen LB. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. Lung Cancer 2009; 66:237 - 244
   PubMed Web of Science ®Google Scholar
• Kleiner HE, Krishnan P, Tubbs J, Smith M, Meschonat C, Shi R, et al. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. J Exp Clin Cancer Res 2009; 28:5
   PubMed Web of Science ®Google Scholar
• Flowers A, Chu QD, Panu L, Meschonat C, Caldito G, Lowery-Nordberg M, et al. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome. Surgery 2009; 146:220 - 226
   Google Scholar
• McClusky DR, Chu Q, Yu H, Debenedetti A, Johnson LW, Meschonat C, et al. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer. Ann Surg 2005; 242:584 - 590
   Google Scholar
• Hiller DJ, Chu Q, Meschonat C, Panu L, Burton G, Li BD. Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer. J Surg Res 2009; 156:265 - 269
   Google Scholar
• Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, et al. Temsirolimus, interferon alfa or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356:2271 - 2281
   PubMed Web of Science ®Google Scholar
• Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 1997; 16:1909 - 1290
   PubMed Web of Science ®Google Scholar
• Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, Cooper JA. Phosphorylation of the capbinding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 1999; 19:1871 - 1880
   PubMed Web of Science ®Google Scholar
• Topisirovic I, Ruiz-Gutierrez M, Borden KL. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res 2004; 64:8639 - 8642
   PubMed Web of Science ®Google Scholar
• Phillips A, Blaydes JP. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 2008; 27:1645 - 1649
   PubMed Web of Science ®Google Scholar
• Buxade M, Parra-Palau JL, Proud CG. The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front Biosci 2008; 13:5359 - 5373
   PubMed Web of Science ®Google Scholar
• Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 2004; 24:6539 - 6549
   PubMed Web of Science ®Google Scholar
• Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, et al. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation. Mol Cell Biol 2007; 27:7405 - 7413
   PubMed Web of Science ®Google Scholar
• Bianchini A, Loiarro M, Bielli P, Busa R, Paronetto MP, Loreni F, et al. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells. Carcinogenesis 2008; 29:2279 - 2288
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177 - 182
   PubMed Web of Science ®Google Scholar
• Chrestensen CA, Shuman JK, Eschenroeder A, Worthington M, Gram H, Sturgill TW. MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines. J Biol Chem 2007; 282:4243 - 4252
   PubMed Web of Science ®Google Scholar
• Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, et al. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat 2009; 121:53 - 64
   PubMed Web of Science ®Google Scholar
• Knauf U, Tschopp C, Gram H. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol Cell Biol 2001; 21:5500 - 5511
   PubMed Web of Science ®Google Scholar
• Buxade M, Parra JL, Rousseau S, Shpiro N, Marquez R, Morrice N, et al. The Mnks are novel components in the control of TNFalpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 2005; 23:177 - 189
   PubMed Web of Science ®Google Scholar
• Dhanjaland P, Fry JR. Determinants of MTT reduction in rat hepatocytes. Biomarkers 1997; 2:111 - 116
   PubMed Web of Science ®Google Scholar
• Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007; 408:297 - 315
   PubMed Web of Science ®Google Scholar
• Cohen P. Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochemical Journal 2009; 425:53 - 54
   PubMed Web of Science ®Google Scholar
• Culjkovic B, Topisirovic I, Borden KL. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E. Cell Cycle 2007; 6:65 - 69
   PubMed Web of Science ®Google Scholar
• Yoshizawa A, Fukuoka J, Shimizu S, Shilo K, Franks TJ, Hewitt SM, et al. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in nonsmall cell lung cancer. Clin Cancer Res 16:240 - 248
   PubMed Web of Science ®Google Scholar
• Fan S, Ramalingam SS, Kauh J, Xu Z, Khuri FR, Sun SY. Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues. Cancer Biol Ther 2009; 8:1463 - 1469
   PubMed Web of Science ®Google Scholar
• Phelps M, Darley M, Primrose JN, Blaydes JP. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha positive breast cancer cells. Cancer Res 2003; 63:2616 - 262
   PubMed Web of Science ®Google Scholar